- Home
- SDOT vs CMND Comparison
SDOT vs CMND Comparison
Compare SDOT & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SDOT | CMND |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 2.2M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SDOT | CMND |
|---|---|---|
| Price | $2.06 | $0.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.0K | ★ 63.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 490.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,929,137.00 | N/A |
| Revenue This Year | $12.76 | N/A |
| Revenue Next Year | $5.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.08 | N/A |
| 52 Week Low | $0.72 | $0.07 |
| 52 Week High | $13.02 | $3.25 |
Technical Indicators
Market Signals| Indicator | SDOT | CMND |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 25.17 |
| Support Level | $1.18 | $0.08 |
| Resistance Level | $2.40 | $1.07 |
| Average True Range (ATR) | 0.25 | 0.10 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 58.23 | 4.70 |
Price Performance
Historical ComparisonAbout SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.